Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4
Eur Urol. 2016 Sep;70(3):e75-6.
doi: 10.1016/j.eururo.2016.02.048.
Epub 2016 Mar 3.
1 Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, USA; Program in Molecular and Cell Biology and Genetics, Drexel University College of Medicine, Philadelphia, PA, USA.
2 Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: daniel.geynisman@fccc.edu.